We now have millions of possibly leaking septic tanks along the shores and banks of our lakes, rivers and streams.
When it comes to something like drain cleaner, you may assume that all ... showers and even septic tanks.
Jeff Shullaw, owner of Too Many Tanks, has a staff of seven to help him keep the tanks clean. Too Many Tanks is adding tanks all the time. Jaysa Smith, an employee, holds a ball python.
Recently, The Post and Courier’s editorial staff again highlighted the urgent issue of septic tank pollution in our coastal waters and the work Mount Pleasant is doing to encourage homeowners to ...
Make sure the side of the tank doesn’t have any invisible slime. Consider a treatment. You can also discourage organism growth by adding an antimicrobial cleaning solution such as the Protec ...
Now, a little more than a year later, she’s making cuts of her own. The neuro-focused biotech is “making changes” to its research team to “reinvigorate the company's drug discovery ...
A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...
Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...
In 2019, Stan­ford Uni­ver­si­ty pro­fes­sor Irv Weiss­man and a col­league pub­lished a pa­per that rep­re­sent­ed a new way to tar­get some ag­gres­sive can­cers.
Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an early look at how receptive public investors could be to biotech listings ...